Response to temozolomide in patients with metastatic colorectal cancer with loss of MGMT expression: A new approach in the era of personalized medicine?

Einat Shacham-Shmueli*, Alexander Beny, Ravit Geva, Arye Blachar, Arie Figer, Dan Aderka

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Pages (from-to)e262-e265
JournalJournal of Clinical Oncology
Issue number10
StatePublished - 1 Apr 2011
Externally publishedYes

Cite this